The bill establishes new provisions regarding health insurance coverage for CAR T-cell therapies in Florida, creating sections 627.64198, 627.6614, and 641.3133 of the Florida Statutes. It defines key terms related to CAR T-cell therapy, including what constitutes a "CAR T cell," the therapy itself, and the definition of a "health care facility." The bill mandates that individual health insurance policies, group health insurance policies, and health maintenance contracts issued or renewed on or after January 1, 2026, cannot refuse to contract with in-network health care facilities for the administration of CAR T-cell therapies. Additionally, these policies cannot deny coverage for the therapies if the health care facility is part of the provider network for other services.

The legislation aims to ensure that patients have access to CAR T-cell therapies without facing barriers from their health insurance providers. By prohibiting refusals to contract with facilities and denying coverage under specified circumstances, the bill seeks to enhance treatment options for patients undergoing this innovative cancer therapy. The effective date for these provisions is set for January 1, 2026.